Dunn W J, Greenberg M J, Callejas S S
J Med Chem. 1976 Nov;19(11):1299-301. doi: 10.1021/jm00233a009.
A series of antitumor triazenes in which the members of the series are physicochemically distinct was designed using the cluster analysis approach as proposed by Hansch and his co-workers. The series that resulted was tested against Sarcoma 180 in the mouse and the antitumor activities were analyzed using regression techniques. The structure-activity relations that resulted are discussed in terms of proposed mechanisms of action.